• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ADAM10在阿尔茨海默病中的作用。

The Role of ADAM10 in Alzheimer's Disease.

作者信息

Yuan Xiang-Zhen, Sun Sen, Tan Chen-Chen, Yu Jin-Tai, Tan Lan

机构信息

Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.

Qingdao Blood Center, Qingdao, China.

出版信息

J Alzheimers Dis. 2017;58(2):303-322. doi: 10.3233/JAD-170061.

DOI:10.3233/JAD-170061
PMID:28409746
Abstract

As a member of the A Disintegrin And Metalloproteinase (ADAM) family, ADAM10 has been identified as the constitutive α-secretase in the process of amyloid-β protein precursor (AβPP) cleavage and plays a critical role in reducing the generation of the amyloid-β (Aβ) peptides. Recent studies have demonstrated its beneficial role in alleviating the pathologic impairment in Alzheimer's disease (AD) both in vitro and in vivo. However, the role of ADAM10 in AD and the underlying molecular mechanisms are still not well established. Increasing evidence indicates that ADAM10 not only reduces the generation of Aβ but may also affect the pathology of AD through potential mechanisms including reducing tau pathology, maintaining normal synaptic functions, and promoting hippocampal neurogenesis and the homeostasis of neuronal networks. Mechanistically, ADAM10 regulates these functions by interacting with postsynaptic substrates in brain, especially synaptic cell receptors and adhesion molecules. Furthermore, ADAM10 protein in platelets seems to be a promising biomarker for AD diagnosis. This review will summarize the role of ADAM10 in AD and highlight its functions besides its role as the α-secretase in AβPP cleavage. Meanwhile, we will discuss the therapeutic potential of ADAM10 in treating AD.

摘要

作为解聚素和金属蛋白酶(ADAM)家族的一员,ADAM10已被确定为淀粉样β蛋白前体(AβPP)裂解过程中的组成型α-分泌酶,并在减少淀粉样β(Aβ)肽的生成中起关键作用。最近的研究表明,它在体外和体内减轻阿尔茨海默病(AD)的病理损伤方面具有有益作用。然而,ADAM10在AD中的作用及其潜在的分子机制仍未完全明确。越来越多的证据表明,ADAM10不仅减少Aβ的生成,还可能通过包括减少tau病理、维持正常突触功能、促进海马神经发生和神经网络稳态等潜在机制影响AD的病理过程。从机制上讲,ADAM10通过与大脑中的突触后底物相互作用来调节这些功能,尤其是突触细胞受体和黏附分子。此外,血小板中的ADAM10蛋白似乎是AD诊断的一个有前景的生物标志物。本综述将总结ADAM10在AD中的作用,并突出其在AβPP裂解中作为α-分泌酶之外的功能。同时,我们将讨论ADAM10在治疗AD方面的治疗潜力。

相似文献

1
The Role of ADAM10 in Alzheimer's Disease.ADAM10在阿尔茨海默病中的作用。
J Alzheimers Dis. 2017;58(2):303-322. doi: 10.3233/JAD-170061.
2
Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's Disease.载脂蛋白E介导的阿尔茨海默病中ADAM10的调节作用
Curr Alzheimer Res. 2017;14(6):578-585. doi: 10.2174/1567205014666170203093219.
3
ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker.ADAM10 在阿尔茨海默病中的作用:天然化合物的药理学调节及其作为外周标志物的作用。
Biomed Pharmacother. 2019 May;113:108661. doi: 10.1016/j.biopha.2019.108661. Epub 2019 Mar 2.
4
Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.抑制ADAM10通过减少低密度脂蛋白受体相关蛋白1(LRP1)胞外域脱落来促进β淀粉样蛋白(Aβ)通过血脑屏障的清除。
Fluids Barriers CNS. 2016 Aug 8;13(1):14. doi: 10.1186/s12987-016-0038-x.
5
Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.过氧化物酶体增殖物激活受体α的激活刺激了ADAM10介导的淀粉样前体蛋白的蛋白水解。
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8445-50. doi: 10.1073/pnas.1504890112. Epub 2015 Jun 15.
6
Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis.人源和小鼠海马神经元中淀粉样前体蛋白分泌酶的不同表达模式:对神经元对淀粉样β蛋白发病机制易感性的物种差异的潜在影响。
J Alzheimers Dis. 2016;51(1):179-95. doi: 10.3233/JAD-150634.
7
Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease.泛素蛋白连接酶E3A(Ube3a)缺乏抑制阿尔茨海默病APPswe/PS1δE9小鼠模型中淀粉样斑块的形成。
Hum Mol Genet. 2017 Oct 15;26(20):4042-4054. doi: 10.1093/hmg/ddx295.
8
Therapeutic approaches to Alzheimer's disease through stimulating of non-amyloidogenic processing of amyloid precursor protein.通过刺激淀粉样前体蛋白的非淀粉样生成加工来治疗阿尔茨海默病的方法。
Eur Rev Med Pharmacol Sci. 2016 Jun;20(11):2389-403.
9
Localization and Trafficking of Amyloid-β Protein Precursor and Secretases: Impact on Alzheimer's Disease.淀粉样β蛋白前体和分泌酶的定位与运输:对阿尔茨海默病的影响
J Alzheimers Dis. 2015;45(2):329-47. doi: 10.3233/JAD-142730.
10
Therapeutic potential of ADAM10 modulation in Alzheimer's disease: a review of the current evidence.ADAM10 调节在阿尔茨海默病中的治疗潜力:对当前证据的综述。
Cell Commun Signal. 2023 Mar 14;21(1):60. doi: 10.1186/s12964-023-01072-w.

引用本文的文献

1
THICAPA modulates amyloid precursor protein processing and alleviates oxidative stress in fibroblasts derived from patients with Familial Alzheimer's disease.THICAPA调节淀粉样前体蛋白加工过程,并减轻家族性阿尔茨海默病患者来源的成纤维细胞中的氧化应激。
Mol Biol Rep. 2025 Aug 19;52(1):835. doi: 10.1007/s11033-025-10930-4.
2
Role of peroxisome proliferator-activated receptor alpha in neurodegenerative diseases and other neurological disorders: Clinical application prospects.过氧化物酶体增殖物激活受体α在神经退行性疾病和其他神经系统疾病中的作用:临床应用前景
Neural Regen Res. 2025 Jun 19. doi: 10.4103/NRR.NRR-D-24-01371.
3
Gray matter microstructure from in-vivo diffusion MRI reflects post-mortem neuropathology severity and clinical progression of Alzheimer's disease.
来自活体扩散磁共振成像的灰质微观结构反映了阿尔茨海默病的死后神经病理学严重程度和临床进展。
medRxiv. 2025 Jun 4:2025.05.30.25328630. doi: 10.1101/2025.05.30.25328630.
4
Cell-specific protein expression in Alzheimer's disease prefrontal cortex.阿尔茨海默病前额叶皮质中的细胞特异性蛋白质表达。
Alzheimers Dement. 2025 Jun;21(6):e70339. doi: 10.1002/alz.70339.
5
Epigenomic subtypes of late-onset Alzheimer's disease reveal distinct microglial signatures.迟发性阿尔茨海默病的表观基因组亚型揭示了不同的小胶质细胞特征。
bioRxiv. 2025 Mar 17:2025.03.15.643144. doi: 10.1101/2025.03.15.643144.
6
Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery.解密非诺贝特在阿尔茨海默病和2型糖尿病中可能的机制作用:真相与谜团
J Cell Mol Med. 2025 Mar;29(5):e70378. doi: 10.1111/jcmm.70378.
7
Potential mechanisms of non-coding RNA regulation in Alzheimer's disease.阿尔茨海默病中非编码RNA调控的潜在机制。
Neural Regen Res. 2024 Dec 7;21(1):265-80. doi: 10.4103/NRR.NRR-D-24-00696.
8
Widespread transposable element dysregulation in human aging brains with Alzheimer's disease.阿尔茨海默病患者衰老大脑中转座子失调广泛。
Alzheimers Dement. 2024 Nov;20(11):7495-7517. doi: 10.1002/alz.14164. Epub 2024 Oct 2.
9
The Six-Transmembrane Enzyme GDE2 Is Required for the Release of Molecularly Distinct Small Extracellular Vesicles from Neurons.六跨膜酶 GDE2 是神经元释放分子不同的小细胞外囊泡所必需的。
Cells. 2024 Aug 24;13(17):1414. doi: 10.3390/cells13171414.
10
GPR37 processing in neurodegeneration: a potential marker for Parkinson's Disease progression rate.神经退行性变中的GPR37加工:帕金森病进展速率的潜在标志物。
NPJ Parkinsons Dis. 2024 Sep 10;10(1):172. doi: 10.1038/s41531-024-00788-x.